A Placeholder Won’t Protect People with Pre-Existing Conditions

President Donald Trump has voiced an “ironclad pledge” to protect patients with pre-existing conditions, but his 2021 budget proposal, which repeats this promise, is silent on how he would do that. At the same time, the Trump administration has taken numerous actions that undermine the Affordable Care Act, including its support of a lawsuit to overturn the ACA and its key protections for people with pre-existing conditions. Continue reading

5th Circuit Decision in Texas v. U.S. Prolongs Uncertainty for Health Care Consumers, Markets

Perhaps knowing their decision would sow consumer confusion and market uncertainty, the 5th Circuit Court of Appeals delayed its decision in the Texas v. U.S. litigation until after the close of open enrollment for Affordable Care Act (ACA) insurance coverage. CHIR’s Sabrina Corlette delves into the consequences of the long-awaited December 18, 2019 decision. Continue reading

Insurers Report on Their Q3 Financial Earnings: Marketplace Profitability, Retail Partnerships, and More

Last month, health insurers reported on their third-quarter (Q3) financial earnings, offering insights on their yearly performance to date and commenting on the market and regulatory challenges they see ahead. CHIR reviewed the quarterly filings and earnings call transcripts for seven publicly traded health insurers, and found that many continue to experience financial stability in the individual market and are closely monitoring major policy changes that could have an impact on their businesses moving forward. Continue reading

DOJ’s Proposed Remedy in Texas v. United States Is an Unrealistic Solution

In supplemental briefings to the Fifth Circuit Court of Appeals, the Department of Justice recently proposed that the Affordable Care Act be struck down in the eighteen plaintiff states bringing suit in Texas v. United States, but upheld in all other states. CHIR’s Emily Curran, Dania Palanker, and Sabrina Corlette explain why this “solution” would upend our system of employer-based coverage and is illogical given the ACA’s national reforms. Continue reading